Online GLP-1 clinics can look similar until you examine what actually arrives at the patient’s door. The medication may be FDA approved or compounded, the advertised price may apply only to one formulation, and a refund can become unavailable as soon as a clinician finishes reviewing the prescription.
SkinnyRx is a telehealth platform operated by Lean Rx, Inc. It connects patients with independent U.S.-licensed medical providers who determine whether prescription weight-loss treatment is appropriate. Its current program includes compounded semaglutide and tirzepatide in several formats, alongside selected FDA-approved medications.
Our SkinnyRx review found a convenient treatment process, no insurance requirement, free shipping and useful continuing clinician access. Important limitations include incomplete public disclosure of the dispensing pharmacies, relatively strict refund timing and an FDA warning letter concerning earlier marketing of compounded GLP-1 products.
Key takeaways
- Compounded injectable semaglutide currently starts around $199 per month, compounded semaglutide tablets around $249, and compounded tirzepatide around $299.
- SkinnyRx also advertises FDA-approved medications, although availability varies; its homepage currently marks Wegovy tablets and Foundayo as unavailable.
- No insurance is required or accepted for the core program. HSA and FSA cards are accepted.
- Licensed providers review each application, and patients complete a refill check-in before subsequent shipments.
- SkinnyRx does not prominently identify its individual compounding pharmacies on its main treatment pages, instead referring generally to state-licensed 503A pharmacies.
- The FDA issued SkinnyRx a warning letter on February 20, 2026, over earlier marketing that obscured the actual compounder and implied equivalence with FDA-approved medication.
SkinnyRx at a glance
| Category | What we found |
|---|---|
| Care model | Online intake, independent clinician review and home delivery |
| Main treatments | Compounded semaglutide and tirzepatide; selected branded GLP-1s |
| Starting compounded prices | $199 semaglutide; $299 tirzepatide |
| Separate membership | None prominently advertised |
| Insurance | Not required or accepted |
| HSA/FSA | Accepted |
| Shipping | Free overnight shipping advertised |
| Follow-up | Provider messaging, refill reviews and app-based tracking |
| Pharmacy disclosure | State-licensed 503A pharmacies referenced, but not prominently named |
| Main concern | FDA warning letter and limited pharmacy-specific transparency |
Information checked August 20, 2026. Pricing, medication availability and pharmacy relationships can change.
How does SkinnyRx work?
The process begins with a short online health assessment. Patients provide information about medical history, current medications and weight-related goals. A licensed clinician then reviews the information and determines whether prescription treatment is appropriate.
SkinnyRx says most patients either receive a prescribing decision online or, when required by state law or clinical circumstances, complete a video consultation. A completed intake does not guarantee approval. Patients who are found ineligible are supposed to receive a full refund.
Once medication is prescribed, fulfillment begins through a partner pharmacy. SkinnyRx advertises free overnight shipping and says patients receive shipment tracking by text or email. Before subsequent refills, members complete another clinical check-in; the provider determines whether treatment should continue or be adjusted.
Members can also contact a clinician through the patient portal about dosage, progress or side effects without an additional consultation charge.
Which medications does SkinnyRx offer?
SkinnyRx currently emphasizes several compounded options:
- Weekly compounded semaglutide injections
- Daily compounded semaglutide tablets or sublingual formulations
- Weekly compounded tirzepatide injections
- Compounded tirzepatide tablets
- Lower-dose or “microdose” treatment pathways
These compounded products are not FDA approved, even though semaglutide and tirzepatide are active ingredients in approved medicines. Compounded drugs are produced for individual prescriptions and are not reviewed by the FDA for finished-product safety, effectiveness or quality before use.
SkinnyRx also advertises FDA-approved products including Wegovy, Zepbound, Mounjaro and Foundayo, although availability changes. Foundayo is an FDA-approved once-daily oral GLP-1 medication containing orforglipron.
One current SkinnyRx Zepbound page incorrectly describes Zepbound as FDA approved for type 2 diabetes. Zepbound is FDA approved for chronic weight management in qualifying adults; Mounjaro is the tirzepatide product approved for type 2 diabetes.
That error should be considered when assessing the precision of the company’s consumer-facing medical content.
How much does SkinnyRx cost?
Current public pricing includes:
| Treatment | Advertised starting price |
| Compounded injectable semaglutide | $199/month |
| Compounded sublingual semaglutide | $199/month |
| Compounded semaglutide tablets | $249/month |
| Compounded tirzepatide injection | $299/month |
| Zepbound | $1,400/month |
| Mounjaro | $1,400/month |
SkinnyRx advertises free shipping and does not prominently add a separate membership charge to these prices. Exact cost can still depend on the formulation, plan and prescription.
Longer or promotional plans deserve closer attention. SkinnyRx’s refund language says discounts can be reversed or proportionally adjusted when a discounted or committed subscription is terminated early. Bundled subscriptions are described as nonrefundable.
Consumers should therefore confirm the total amount charged today, rather than relying only on the monthly equivalent shown in an advertisement.
Insurance, labs and clinical support
SkinnyRx does not require insurance and states that it accepts major credit cards plus HSA and FSA payments. For people with strong insurance coverage for Wegovy or Zepbound, this cash-pay model may be less attractive than a clinic offering prior-authorization assistance.
We did not find a clear statement that routine laboratory testing is included with every treatment plan. The prescribing clinician may determine that testing is appropriate based on medical history and medication choice, so patients should ask whether labs are required and who pays.
SkinnyRx’s ongoing-care model includes refill reviews, provider messaging and digital tracking tools. Its app includes medication and weight tracking plus meal-planning features.
Pharmacy transparency and the FDA warning letter
SkinnyRx says compounded prescriptions are dispensed through state-licensed 503A pharmacies. However, its main public treatment pages do not clearly name the pharmacy that will prepare a particular patient’s prescription.
That matters because patients should be able to verify the dispensing pharmacy with its state board of pharmacy.
The issue is particularly relevant after the FDA’s February 20, 2026 warning letter to Lean Rx, Inc. dba SkinnyRx. The FDA said website images labeled compounded products with the SkinnyRx name in a way that misleadingly suggested SkinnyRx itself was the compounder. The agency also objected to claims implying that the compounded products were equivalent to, or had been evaluated like, FDA-approved medications.
Current SkinnyRx pages now contain prominent disclosures that compounded products are not FDA approved. We did not locate a subsequent FDA close-out letter confirming that the agency has formally closed the warning-letter matter.
The broader regulatory environment is also tightening. The FDA now considers the semaglutide and tirzepatide shortages resolved and reminds 503A pharmacies that they generally cannot regularly compound products that are essentially copies of commercially available medicines unless applicable patient-specific conditions are met.
Benefits and limitations
Potential benefits
SkinnyRx may appeal because it offers:
- Multiple injectable and oral treatment formats
- No separate membership fee prominently advertised
- Free expedited shipping
- Provider review before prescribing
- Monthly refill monitoring
- Ongoing clinician messaging
- HSA/FSA payments
- Both compounded and FDA-approved pathways
Meaningful limitations
Consumers should also consider:
- Compounded products are not FDA approved
- Individual compounding pharmacies are not prominently disclosed
- Insurance and prior-authorization assistance are limited
- Refund eligibility ends early in the fulfillment process
- Bundled subscriptions may be nonrefundable
- FDA issued SkinnyRx a warning letter in February 2026
- Current Zepbound marketing contains an inaccurate FDA-indication statement
- Oral and microdosed compounded formulations have less formulation-specific evidence than FDA-approved products
Cancellation and refunds
SkinnyRx allows a full refund before the licensed provider completes the prescription review. Once the prescription has been completed and fulfillment begins, the order becomes nonrefundable.
Future subscription months can be cancelled before the next shipment is prepared. Partially used subscription periods are generally nonrefundable, while bundled plans cannot ordinarily be refunded.
This makes timing important. Patients planning to stop should cancel well before the next refill review or fulfillment process begins and keep written confirmation.
Safety and eligibility considerations
Common adverse effects associated with semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation and abdominal discomfort. FDA-approved GLP-1 labeling also contains warnings involving pancreatitis, gallbladder disease, severe gastrointestinal reactions, dehydration-related kidney injury and serious hypersensitivity.
Approved weight-management products also have important contraindications and pregnancy precautions. Medication selection and dose escalation should therefore be individualized rather than determined solely from an online price comparison.
Compounded products create additional considerations because concentrations and dosing instructions can differ. As of May 31, 2026, the FDA had received 990 adverse-event reports involving compounded semaglutide and more than 730 involving compounded tirzepatide, although the agency notes that these reports do not always establish that the medication caused the event.
Patients should confirm the vial concentration, prescribed dose and syringe measurement before injecting compounded medication.
Who may find SkinnyRx worth considering?
SkinnyRx may appeal to adults who expect to pay cash, prefer remote prescribing and want a choice between injectable and oral treatment formats.
It may be less suitable for people who want extensive insurance assistance, need a named pharmacy before enrollment, prefer structured dietitian or behavioral coaching, or want exclusively FDA-approved treatment.
Questions to ask before enrolling
- What exact medication and formulation will I receive?
- Is the treatment FDA approved or compounded?
- Which pharmacy will fill my prescription?
- What is my first payment and normal renewal price?
- Does my price change as my dose increases?
- Are laboratory tests required or included?
- How quickly can I reach a clinician about side effects?
- When does my order become nonrefundable?
- Does cancelling a bundled plan reverse promotional discounts?
- What alternative treatment is available if compounding rules change?
Final assessment
SkinnyRx offers a convenient self-pay pathway with several medication formats, free shipping and continuing clinician access. Its starting prices are also relatively easy to identify compared with some competitors.
The main concerns involve transparency and regulatory context. The individual pharmacy is not prominently disclosed before enrollment, compounded medication remains subject to evolving federal restrictions, and the FDA warning letter makes precise product labeling particularly important.
SkinnyRx may be worth considering after clinical evaluation if the patient receives clear written confirmation of the medication, pharmacy, total cost and cancellation terms. The distinction between compounded and FDA-approved treatment should remain central to that decision.
Frequently asked questions
Is SkinnyRx legitimate?
SkinnyRx is an identifiable U.S. telehealth platform operated by Lean Rx, Inc. It connects patients with independent licensed medical professionals and partner pharmacies. The FDA warning letter concerned how compounded products were marketed; it did not state that every SkinnyRx prescription or service was illegitimate.
How much does SkinnyRx cost?
Compounded injectable semaglutide currently starts around $199 per month and tirzepatide around $299. Oral compounded semaglutide starts around $199–$249 depending on formulation.
Does SkinnyRx accept insurance?
No insurance is required, and SkinnyRx operates primarily as a cash-pay service. It accepts HSA and FSA cards.
Are SkinnyRx compounded medications FDA approved?
No. SkinnyRx’s current pages acknowledge that compounded semaglutide and tirzepatide have not been approved or evaluated by the FDA as finished products.
Which pharmacy does SkinnyRx use?
SkinnyRx says it uses U.S. state-licensed 503A pharmacies but does not prominently identify the specific pharmacy on its main medication pages. Ask for the pharmacy name before treatment and verify its license independently.
Can I cancel SkinnyRx?
Future shipments can be cancelled, but an individual order generally becomes nonrefundable once the provider completes the prescription review and fulfillment begins. Bundled plans have additional restrictions.
